Learn how new agreements aim to lower the cost of weight loss drugs like Wegovy and Zepbound for both insured and uninsured ...

GLP-1 medications have taken America by storm, moving beyond clinical tools and becoming status symbols. Once accessible to only the wealthy and well-connected, they are now prescribed in clinics ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat healthily and exercise regularly. Injectable weight loss medications — also ...

Weight loss drugs are proving to be super popular among many workers with job-based health insurance. But GLP-1 medications are busting their employers’ budgets, leading some firms to rethink their ...

(Reuters) - An influential drug pricing watchdog on Tuesday said popular GLP-1 weight-loss injections have become more cost-effective as their prices have fallen and studies have shown proof of their ...

Popular weight loss drugs like Wegovy and Zepbound will soon cost Americans less under a new deal announced by President Donald Trump on Thursday. Agreements with drugmakers Novo Nordisk and Eli Lilly ...

Millions of Americans will soon have direct access to popular weight-loss drugs at far lower prices than they pay now. That’s due to a deal announced between President Trump and pharmaceutical giants ...

ICER rates semaglutide and tirzepatide as cost effective vs lifestyle modifications Lilly's tirzepatide shows "promising but inconclusive" cost-effectiveness vs Novo's semaglutide Net prices of both ...